New Data, New Perspectives in Ovarian Cancer: Experts Discuss the Current Paradigm and Long-term Benefits of PARP Inhibitor Therapy

Download All
Gain a deeper understanding of how PARP inhibitors fit into current treatment approaches in ovarian cancer in this on-demand webcast and audio podcast, then download the slides for use in your own presentations.
Nicoletta Colombo, MD
person default
Philipp Harter, MD, PhD
person default
Alexandra Leary, MD, PhD

Downloadable Slidesets

Download this slideset on the current advances and evolving landscape of PARP inhibitors for patients with ovarian cancer.

Nicoletta Colombo, MD Released: September 3, 2021

Download this slideset discussing a clinical case of PARP inhibitors for a patient with ovarian cancer.

person default Philipp Harter, MD, PhD Released: September 3, 2021

Download this slideset on maintenance strategies for newly diagnosed patients with BRCA1/2-mutated ovarian cancer.

person default Alexandra Leary, MD, PhD Released: September 3, 2021

Download this short summary slideset of key takeaway points from a live presentation on the global perspectives on the current paradigm and long term benefits of PARPi in the treatment of ovarian cancer. 

Nicoletta Colombo, MD person default Philipp Harter, MD, PhD person default Alexandra Leary, MD, PhD Released: September 10, 2021
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
AstraZeneca

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue